These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30911407)
1. Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome. Dorado B; Pløen GG; Barettino A; Macías A; Gonzalo P; Andrés-Manzano MJ; González-Gómez C; Galán-Arriola C; Alfonso JM; Lobo M; López-Martín GJ; Molina A; Sánchez-Sánchez R; Gadea J; Sánchez-González J; Liu Y; Callesen H; Filgueiras-Rama D; Ibáñez B; Sørensen CB; Andrés V Cell Discov; 2019; 5():16. PubMed ID: 30911407 [TBL] [Abstract][Full Text] [Related]
2. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach. Rajeev M; Ratan C; Krishnan K; Vijayan M Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042 [TBL] [Abstract][Full Text] [Related]
6. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models. Benedicto I; Dorado B; Andrés V Cells; 2021 May; 10(5):. PubMed ID: 34064612 [TBL] [Abstract][Full Text] [Related]
7. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS. Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398 [TBL] [Abstract][Full Text] [Related]
9. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome. Hamczyk MR; Andrés V Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948 [TBL] [Abstract][Full Text] [Related]
10. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment. Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V Cells; 2020 Mar; 9(3):. PubMed ID: 32182706 [TBL] [Abstract][Full Text] [Related]
11. Generation of a Hutchinson-Gilford progeria syndrome monkey model by base editing. Wang F; Zhang W; Yang Q; Kang Y; Fan Y; Wei J; Liu Z; Dai S; Li H; Li Z; Xu L; Chu C; Qu J; Si C; Ji W; Liu GH; Long C; Niu Y Protein Cell; 2020 Nov; 11(11):809-824. PubMed ID: 32729022 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review. Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298 [TBL] [Abstract][Full Text] [Related]
13. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V Cells; 2020 Oct; 9(10):. PubMed ID: 33049978 [TBL] [Abstract][Full Text] [Related]
14. A conserved splicing mechanism of the LMNA gene controls premature aging. Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900 [TBL] [Abstract][Full Text] [Related]
15. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome. Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863 [TBL] [Abstract][Full Text] [Related]
16. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome. Finley J Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605 [TBL] [Abstract][Full Text] [Related]
17. Hutchinson-Gilford progeria syndrome as a model for vascular aging. Brassard JA; Fekete N; Garnier A; Hoesli CA Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290 [TBL] [Abstract][Full Text] [Related]
18. Hutchinson-Gilford Progeria Syndrome-Current Status and Prospects for Gene Therapy Treatment. Piekarowicz K; Machowska M; Dzianisava V; Rzepecki R Cells; 2019 Jan; 8(2):. PubMed ID: 30691039 [TBL] [Abstract][Full Text] [Related]